| Literature DB >> 35736411 |
Abstract
Resveratrol, a plant-derived polyphenol, is an intensively studied compound with widely documented positive effects on health. Antioxidant activity is the property most often mentioned as responsible for its beneficial effects. Therefore, since the adverse effect of ionizing radiation is primarily related to the induction of oxidative stress, the question arises of whether the use of resveratrol could have a radioprotective effect. This paper summarizes the data on the cytoprotective activity of resveratrol and pieces of evidence for the potential interplay between response to radiation and resveratrol activity. The paper focuses on changes in the metabolic profile of cells and organisms induced by ionizing radiation and exposure to resveratrol. The comparison of metabolic changes induced by both factors provides a rationale for the potential mechanism of the radioprotective effects of resveratrol.Entities:
Keywords: metabolomics; radioprotection; resveratrol
Year: 2022 PMID: 35736411 PMCID: PMC9229206 DOI: 10.3390/metabo12060478
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
An overview of studies on the radioprotective effects of resveratrol.
| Research Model | Resveratrol Dose | Radiation Dose | The Observed Effect of Resveratrol | Reference |
|---|---|---|---|---|
| bone marrow cells from CBA/CaJ irradiated mice | 100 mg/kg/day from 2 days before the irradiation until the end of the experiment | 3 Gy, γ radiation | 2.8-fold reduction of total chromosome aberrations, including gaps, dicentrics, and Robertsonian translocations for the resveratrol + radiation group compared to the radiation group | [ |
| peripheral blood cells and bone marrow cells from irradiated C57BL/6-Ly-5.1 mice | 20 mg/kg/day from 7 days before to 30 days after irradiation | 6.0 Gy or 7.2 Gy, 137 Cs irradiator, TBI | increased survival after TBI, decreased acute and long-term bone marrow damage, reduced oxidative stress after exposure to 7.2 Gy in the resveratrol group | [ |
| blood and bone marrow from irradiated Swiss mice | 7 mg/kg/day or 28 mg/kg/day for 2 weeks | 5 Gy and 10 Gy total doses in 0.5 Gy and 1 Gy fractions, X-radiation, TBI | reduction in the number of micronuclei in reticulocytes in the resveratrol + radiation group when compared to the radiation group | [ |
| peripheral blood lymphocyte from irradiated NMRI mice | 50 mg/kg or 100 mg/kg 2 h before irradiation | 2 Gy, γ radiation | reduction of radiation-induced DNA damage (assessed by comet assay) in the resveratrol group | [ |
| human peripheralblood lymphocytes | 2.2, 22 or 220 µM 1 h before irradiation | 2 Gy γ radiation | reduction in chromosome aberrations after irradiation with maximal protection observed for 2.2 µM dose; however, resveratrol induced chromosomal aberrations in the absence of irradiation | [ |
| human peripheral blood lymphocytes | 20 µM or 40 µM 3 h before irradiation | 0.5 Gy or 1 Gy, X-radiation | in the 40 µM resveratrol group increased level of dicentric chromosomes induced by radiation; resveratrol alone did not induce DNA or chromosome damage | [ |
| mouse embryonic stem cells | 10 µM 48 h before irradiation | 5 Gy, X-radiation | improvement of the viability of irradiated cells and acceleration of DNA damage repair | [ |
| ovaries from irradiated Wistar rats | 10 mg/kg or 100 mg/kg 24 h before irradiation | 720 cGy, photon, TBI | increased follicle count in ovaries after irradiation and increase of antioxidant enzymes activity in the resveratrol group | [ |
| testes from irradiated NMRI mice | 100 mg/kg/day for two days before irradiation | 2 Gy, γ radiation, TBI | reduction of spermatogenic arrest, thickening of the basal lamina, decreased sperm density and vacuolation in the resveratrol group; resveratrol increased atrophy of seminiferous tubules | [ |
| small intestines of irradiated C57BL/6 N mice | 40 mg/kg/day1 day before and 5 days after irradiation | 7 Gy, 137 Cs irradiator, partial-body irradiation | normalization of the intestinal cell morphology in irradiated mice (enhanced regeneration of intestinal crypt cells, increased villi length, shorter basal lamina length) | [ |
| organotypic entorhinal–hippocampal slice cultures generated from nestin-CFPnuc C57BL/J6 mice | 15 µM 2 h before irradiation until 48 h after irradiation | 4.5, 8, 12, or 16 Gy, X-radiation | increased number of nestin-positive neural progenitor cells in the resveratrol + radiation group when compared to the radiation group | [ |
Radiation-induced modulation of metabolic pathways. Pathways were identified using the MetaboAnalyst 5.0 software based on radiation-affected metabolites.
| Experimental Model | Radiation Dose and Experimental Design | Affected Metabolic Pathway | Reference |
|---|---|---|---|
| murine liver | 3 Gy and 7.8 Gy, proton and gamma, 4 and 11 days | GSH metabolism; Ala/Asp/Glu metabolism; Gly/Ser/Thr metabolism; TCA cycle; Glycerophospholipid metabolism; Pyruvate metabolism | [ |
| rat jejunum, spleen, liver and plasma | 2 Gy and 6 Gy X-ray, 1, 2, and 3 days | Gln/Glu metabolism; Phe/Tyr/Trp biosynthesis; Taurine and hypotaurine metabolism; Ala/Asp/Glu metabolism; GSH metabolism; Phe metabolism; Gly/Ser/Thr metabolism; Glyoxylate and dicarboxylate metabolism; Arg biosynthesis; TCA cycle; Arg/Pro metabolism; Glycerophospholipid metabolism; Primary bile acid biosynthesis | [ |
| cardiomyocytes | 2 Gy, photons, 2 days | Taurine and hypotaurine metabolism; Gln/Glu metabolism; GSH metabolism; Gly/Ser/Thr metabolism; Ala/Asp/Glu metabolism; Glyoxylate and dicarboxylate metabolism; Arg biosynthesis; Glycerophospholipid metabolism | [ |
| murine hearts | 2 Gy, photons, 2 days, 20 weeks | Gln/Glu metabolism; Phe/Tyr/Trp biosynthesis; Ala/Asp/Glu metabolism; Gly/Ser/Thr metabolism; Glyoxylate and dicarboxylate metabolism; Arg biosynthesis; GSH metabolism; Inositol phosphate metabolism; Tyr metabolism | [ |
| murine hearts | 2 Gy, photons, 20 weeks | Glycerophospholipid metabolism; Lipids metabolism | [ |
| whole mice, 31P NMR MRI | 7 Gy, X-ray, 0–14 days | Arg/Pro metabolism; Gly/Ser/Thr metabolism | [ |
| murine urine | 8 Gy, X-ray, 7 days | Taurine and hypotaurine metabolism; TCA cycle; Ala/Asp/Glu metabolism; Butanoate metabolism; Gly/Ser/Thr metabolism; Gln/Glu metabolism; Phe metabolism; Arg biosynthesis; Propanoate metabolism; Glyoxylate and dicarboxylate metabolism; Glycerophospholipid metabolism; Arg/Pro metabolism; Primary bile acid biosynthesis | [ |
| fibroblasts | 1 Gy and 5 Gy, gamma, 1, 2, and 3 days | Lipids metabolism; Phe/Tyr/Trp biosynthesis; Phe metabolism; GSH metabolism; Arg/Pro metabolism; Glycerophospholipid metabolism; Arg biosynthesis; Aminoacyl-tRNA biosynthesis; Ubiquinone and another terpenoid-quinone biosynthesis; Pantothenate and CoA biosynthesis; Ether lipid metabolism; Gly/Ser/Thr metabolism; Cys/Met metabolism; Trp metabolism; Tyr metabolism | [ |
| fibroblasts, B lymphoblastoid cells | 0.02 Gy, 0.1 Gy, and 1 Gy, X-ray, 1 and 10 h. | Purine metabolism; Cys/Met metabolism | [ |
| murine urine | 1.1 Gy and 4.4 Gy, X-ray, 2 days | intermediates in the Trp metabolism and Ile catabolism; TCA cycle; Pyruvate metabolism; Glycolysis/Gluconeogenesis; Ala/Asp/Glu metabolism; Glyoxylate and dicarboxylate metabolism; Cys/Met metabolism | [ |
| murine liver | 8.5 Gy, gamma, 1 and 4 days | Lipids metabolism; GSH metabolism; Porphyrin and chlorophyll metabolism; Pyrimidine metabolism; Glycerophospholipid metabolism; Primary bile acid biosynthesis; Purine metabolism | [ |
| murine intestines | 2 Gy or 1.6 Gy, gamma or heavy-ion, 2 months | Phe/Tyr/Trp biosynthesis; Phe metabolism; Ala/Asp/Glu metabolism; beta-Ala metabolism; His metabolism; Pyruvate metabolism; GSH metabolism; Trp metabolism; Pyrimidine metabolism; Glycolysis/Gluconeogenesis; Pantothenate and CoA biosynthesis; TCA cycle | [ |
| bone marrow, ileum, liver, muscle, lung, serum, urine of mice | 6 Gy, gamma, 12 h | Gln/Glu metabolism; Taurine and hypotaurine metabolism; Phe/Tyr/Trp biosynthesis; GSH metabolism; Ala/Asp/Glu metabolism; Phe metabolism; Purine metabolism; Arg biosynthesis; Pyrimidine metabolism; Arg/Pro metabolism; Glycerophospholipid metabolism; Amino sugar and nucleotide sugar metabolism; Primary bile acid biosynthesis; Pentose and glucuronate interconversions | [ |
| urine and serum of rhesus monkeys | 4 Gy, gamma, up to 60 days | Phe/Tyr/Trp biosynthesis; TCA cycle; Phe metabolism; Glyoxylate and dicarboxylate metabolism | [ |
GSH—glutathione; CoA—coenzyme A; amino acids; Ala—alanine; Arg—arginine; Asn—asparagine; Asp—aspartate; Cys—cysteine; Gln—glutamine; Glu—Glutamate; Gly—glycine; Ile—isoleucine; Met—methionine; Phe—phenylalanine; Pro—proline; Ser—serine; Tyr—tyrosine, Trp—tryptophan.
Resveratrol-related changes in metabolic pathways. Pathways were identified using the MetaboAnalyst 5.0 software based on resveratrol-affected metabolites.
| Experimental Model | Resveratrol Dose and Experimental Design | Affected Metabolic Pathway | Reference |
|---|---|---|---|
| plasma from Sprague –Dawley rats subjected to trauma-hemorrhagic shock | 30 mg/kg administered 30 min after hemorrhage | Synthesis and degradation of ketone bodies; His metabolism; Butanoate metabolism; TCA cycle; Glyoxylate and dicarboxylate metabolism; Lys degradation; Aminoacyl-tRNA biosynthesis; Biotin metabolism; beta-Ala metabolism; Pyruvate metabolism; Ala/Asp/Glu metabolism; Val/Leu/Ile degradation; Glycolysis/Gluconeogenesis; Tyr metabolism | [ |
| urine and feces of Wistar rats | 50 mg/kg or 250 mg/kg after 12 h of food deprivation | Taurine and hypotaurine metabolism; Pyruvate metabolism; TCA cycle; Gly/Ser/Thr metabolism; Ala/Asp/Glu metabolism; Glycolysis/Gluconeogenesis | [ |
| abdominal muscle tissue from ApoE-/- mice fed with a high fat diet | 10 mg/kg/day for 24 weeks | Pentose phosphate pathway; pentose and glucuronate interconversions; galactose metabolism; fructose and mannose metabolism; Ala/Asp/Glu metabolism; Glyoxylate and dicarboxylate metabolism | [ |
| blood, urine, adipose tissue, and skeletal muscle from men with metabolic syndrome | 150 mg/day or 1 g/day for 4 months | Linoleic acid metabolism; Ubiquinone and another terpenoid-quinone biosynthesis; His metabolism, Tyr metabolism; Trp metabolism; Biosynthesis of unsaturated fatty acids; Phe/Tyr/Trp biosynthesis | [ |
| fibroblasts with mitochondrial Complex 1 disorder | 50 µM for 24 h | Lipids transformations; Gln/Glu metabolism; Taurine and hypotaurine metabolism; Ala/Asp/Glu metabolism; Gly/Ser/Thr metabolism; Glyoxylate and dicarboxylate metabolism; Arg biosynthesis; GSH metabolism; Inositol phosphate metabolism; Arg/Pro metabolism; Aminoacyl-tRNA biosynthesis; Val/Leu/Ile biosynthesis; Val/Leu/Ile degradation; Nitrogen metabolism | [ |
| MCF-7 and MDA-MB-231 breast cancer cells | 100 µM for 72 h | Phe metabolism; Arg biosynthesis; Ala/Asp/Glu metabolism; Gln/Glu metabolism; Arg/Pro metabolism; Taurine and hypotaurine metabolism; Phe metabolism; Trp metabolism; Arachidonic acid metabolism; His metabolism; Gly/Ser/Thr metabolism; GSH metabolism; Glyoxylate and dicarboxylate metabolism; Cys/Met metabolism; Tyr metabolism; Aminoacyl-tRNA biosynthesis; Val/Leu/Ile biosynthesis; beta-Ala metabolism; Lipids transformations | [ |
| hearts from irradiated C57Bl/6NCrl mice | 5 mg/kg/day or 25 mg/kg/day from 4 weeks before until 2 weeks after irradiation | Lipids transformations; Gly/Ser/Thr metabolism; Taurine and hypotaurine metabolism; Glyoxylate and dicarboxylate metabolism; Glycerophospholipid metabolism; GSH metabolism; Primary bile acid biosynthesis | [ |
GSH—glutathione; CoA—coenzyme A; amino acids; Ala—alanine; Arg—arginine; Asn—asparagine; Asp—aspartate; Cys—cysteine; Gln—glutamine; Glu—Glutamate; Gly—glycine; His – histidine; Ile—isoleucine; Leu—leucine; Met—methionine; Phe—phenylalanine; Pro—proline; Ser—serine, Tyr—tyrosine; Trp—tryptophan; Val—valine.
Figure 1Cellular metabolic pathways affected by ionizing radiation and resveratrol. The diagram illustrates the connections between selected pathways modulated by resveratrol (purple boxes), radiation (orange boxes), and both factors (green boxes).
Figure 2Hypothetical metabolism-related mechanism of radioprotection by resveratrol: main mechanisms of radiation toxicity and protective effects of resveratrol. IR—ionizing radiation.